IMUTEX
Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO plc to accelerate the development of a Broad-Spectrum Influenza Vaccine (BIV) and a Zika Vaccine. The development of BIV and Zika vaccines are key public health priorities identified by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) in the United States.
IMUTEX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.imutex.com
Total Employee:
1+
Status:
Active
Contact:
+44 207 036 8550
Total Funding:
14 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Kimbell Duncan Director @ Imutex
Director
Investors List
Official Site Inspections
http://www.imutex.com Semrush global rank: 5.4 M Semrush visits lastest month: 1.56 K
- Host name: 253.237.197.35.bc.googleusercontent.com
- IP address: 35.197.237.253
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
More informations about "Imutex"
Vaccine Programmes | Vaccine Development | Imutex
Imutex Limited is a joint venture between PepTcell (51%) and hVIVO plc (49%). The Imutex vaccines have been designed to provide a broadly protective immune response against disease through viral clearance by cytotoxic T cells …See details»
Imutex - Crunchbase Company Profile & Funding
Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO plc to accelerate the development of a Broad-Spectrum Influenza Vaccine (BIV) and a Zika Vaccine. …See details»
Imutex Company Profile | Management and Employees List
Imutex Profile and History Imutex Limited (Imutex), hVIVO's 49% joint venture with SEEK Group Ltd (SEEK), is developing two novel vaccine candidates, FLU-v and AGS-v. FLU-v is a first-in …See details»
Our Leadership | Vaccine Programme Leadership - IMUTEX
Brendan Buckley is co-founder and non-executive Director at hVIVO plc. Brendan was Chief Medical Officer of ICON plc until 2017, prior to which he co-founded Firecrest Clinical, a …See details»
IMUTEX Ltd - LinkedIn
IMUTEX Ltd | 128 followers on LinkedIn. A joint venture between SEEK Group and hVIVO, part of Open Orphan plc, to accelerate the development of FLU-v & AGS-v | Imutex Limited, formed …See details»
Imutex Company Profile 2024: Valuation, Funding & Investors
Imutex General Information Description. Developer of vaccines against influenza (flu) and mosquito-borne diseases, such as flu, zika, and other flaviviruses. The company engages in …See details»
IMUTEX Company Profile - Office Locations, Competitors, Revenue …
IMUTEX $20.4 m in total funding,. See insights on IMUTEX including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Imutex - VentureRadar
Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO plc to accelerate the development of a Broad-Spectrum Influenza Vaccine (BIV) and a Zika Vaccine. …See details»
About us | Imutex | Vaccine Development
Imutex Limited, formed in 2016, is a joint venture between PepTcell and hVIVO, to accelerate the development of a Broad-Spectrum ‘Universal’ Influenza Vaccine, FLU-v, and a Mosquito …See details»
Imutex Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Imutex Ltd including stock price, company news, executives, board members, and contact informationSee details»
Imutex - Contacts, Employees, Board Members, Advisors & Alumni …
Imutex, a startup with a Phase IIa-ready universal flu vaccine.See details»
Imutex - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Imutex . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 30. About. Imutex is actively using …See details»
Flu Vaccine Programme | Influenza Vaccine | Imutex
Imutex is leveraging technology licensed from PepTcell to develop a Broad-Spectrum ‘Universal’ Influenza Vaccine (BIV), called FLU-v, against multiple flu strains. FLU-v works by targeting …See details»
SEEK, hVIVO invest £14M to create universal flu vaccine joint venture
Apr 28, 2016 Imutex will use the resources to progress on two fronts. The most advanced of the two programs is FLU-v, a universal influenza vaccine candidate designed to activate B and T …See details»
Seqirus joins universal flu vaccine partnership UIVI
Jul 10, 2018 Imutex is a joint venture between clinical research specialist hVIVO and drug development organization SEEK Group.See details»
Imutex - Funding, Financials, Valuation & Investors - Crunchbase
Imutex, a startup with a Phase IIa-ready universal flu vaccine. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... How much …See details»
Universal flu vaccine biotech seeks Big Pharma partnership for …
Jun 19, 2018 Imutex is a joint venture between clinical research specialist hVIVO and drug development organization SEEK Group; the team has been working on its universal flu …See details»
Mosquito-Borne Diseases | Mosquito Vaccine | Imutex
Imutex collaborated with the National Institute of Allergy and Infectious Disease (NIAID) team to perform the vaccine’s “First in Man” Phase I clinical trial in partnership with the NIH Clinical …See details»
Imutex - News, Articles etc. - European Pharmaceutical Review
Aug 3, 2022 Imutex Show advanced filters. Reset all . article Developing broad-spectrum vaccines that target the heart of mutating viruses. 3 August 2022 | By Alexandre Le Vert …See details»
News | Vaccine Programme News & Updates | Imutex
The latest Imutex company news, events and media coverage as well as the latest scientific papers on influenza and mosquito-borne disease vaccines. Toggle navigation. Skip to content. …See details»